News Release
  November 25, 2013

CONTACT:

Karen Kreeger

215-349-5658
karen.kreeger@uphs.upenn.edu

Perelman School of Medicine


This release is available online at
http://www.uphs.upenn.edu/news/News_Releases/2013/11/aaas/

Five Penn Faculty Earn Distinction as AAAS Fellows

PHILADELPHIA — Five faculty members from the University of Pennsylvania have been named fellows of the American Association for the Advancement of Science (AAAS). Three are from the Perelman School of Medicine, one is from the School of Arts and Sciences, and one has appointments both at Penn Medicine and The Children’s Hospital of Philadelphia.

They are among 388 members of AAAS awarded the distinction this year for “their efforts toward advancing science applications that are deemed scientifically or socially distinguished.”

Frederic D. Bushman, PhD, professor of Microbiology at the Perelman School of Medicine, was elected for distinguished contributions to microbiology, including methods development, bioinformatics and translational research to characterize host pathogen interactions.

Andrew Dancis, MD, associate professor of Medicine at the Perelman School of Medicine, was elected for pioneering discoveries of exceptional significance on the fundamental mechanisms by which organisms acquire, distribute, utilize and regulate the essential metal iron.

Robert W. Doms, MD, PhD, professor of Pathology and Laboratory Medicine at the Perelman School of Medicine and pathologist-in-chief and chair of Pathology and Laboratory Medicine at The Children’s Hospital of Philadelphia, was elected for his significant discoveries in virus entry, including his work in identifying host cell pathways that HIV and other disease-causing viruses use to infect cells, and in investigating how AIDS develops.

J. Kevin Foskett, PhD, chair of the department of Physiology at the Perelman School of Medicine, was elected for pioneering studies of the InsP3R calcium channel and molecular mechanisms and roles of calcium signaling in Alzheimer's disease, programmed cell death and cellular bioenergetics.

Philip A. Rea, DPhil, professor of Biology in the School of Arts and Sciences and Rebecka and Arie Belldegrun Distinguished Director of the Roy and Diana Vagelos Program in Life Sciences & Management, was elected for outstanding fundamental research discoveries on the membrane transport and detoxification of xenobiotics and for distinguished accomplishments and creativity in science education.
The new Fellows will be honored on Saturday, Feb. 15, at the AAAS Fellows Forum during the 2014 AAAS Annual Meeting in Chicago.

###

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.